4.7 Article

Hyperinsulinemia Drives Epithelial Tumorigenesis by Abrogating Cell Competition

期刊

DEVELOPMENTAL CELL
卷 53, 期 4, 页码 379-+

出版社

CELL PRESS
DOI: 10.1016/j.devcel.2020.04.008

关键词

-

资金

  1. MEXT/JSPS KAKENHI [26114002, 16H02505]
  2. Takeda Science Foundation
  3. Japan Agency for Medical Research and Development (Project for Elucidating and Controlling Mechanisms of Aging and Longevity) [17938731]
  4. Grants-in-Aid for Scientific Research [16H02505, 26114002] Funding Source: KAKEN

向作者/读者索取更多资源

Metabolic diseases such as type 2 diabetes are associated with increased cancer incidence. Here, we show that hyperinsulinemia promotes epithelial tumorigenesis by abrogating cell competition. In Drosophila eye imaginal epithelium, oncogenic scribble (scrib) mutant cells are eliminated by cell competition when surrounded by wild-type cells. Through a genetic screen, we find that flies heterozygous for the insulin receptor substrate chico allow scrib cells to evade cell competition and develop into tumors. Intriguingly, chico is required in the brain's insulin-producing cells (IPCs) to execute cell competition remotely. Mechanistically, chico downregulation in IPCs causes hyperinsulinemia by upregulating a Drosophila insulin Dilp2, which activates insulin-mTOR signaling and thus boosts protein synthesis in scrib cells. A diet-induced increase in insulin levels also triggers scrib tumorigenesis, and pharmacological repression of protein synthesis prevents hyperinsulinemia-induced scrib overgrowth. Our findings provide an in vivo mechanistic link between metabolic disease and cancer risk via systemic regulation of cell competition.

作者

我是这篇论文的作者
点击您的名字以认领此论文并将其添加到您的个人资料中。

评论

主要评分

4.7
评分不足

次要评分

新颖性
-
重要性
-
科学严谨性
-
评价这篇论文

推荐

暂无数据
暂无数据